Table 1 Comparison between TMX sensitive and TMX resistant groups regarding the different studied parameters.
From: Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer
TMX-sensitive group | TMX-resistant group | Test value | P value | |
|---|---|---|---|---|
N = 50 | N = 50 | |||
TUG-1 | ||||
Median (IQR) | 39.75 (32.86–45.99) | 210.62 (172.64–220.57) | 7.127 | < 0.001** |
Range | 23.03–136.35 | 36.60–448.22 | ||
miRNA 186-5p | ||||
Median (IQR) | 168.78 (138.51–180.81) | 376.08 (339.77–428.06) | 5.933 | < 0.001** |
Range | 111.73–568.78 | 111.07–620.37 | ||
SIRT3 | ||||
Median (IQR) | 3.57 (2.55–4.54) | 2.85 (2.14–3.47) | − 2.642 | 0.008** |
Range | 0.46–9.78 | 0.38–5.69 | ||
PPAR alpha | ||||
Median (IQR) | 1.21 (0.75–2.77) | 0.83 (0.64–1.05) | − 2.902 | 0.004** |
Range | 0.29–4.56 | 0.35–2.92 | ||
HIF-1 | ||||
Median (IQR) | 1.99 (1.73–2.95) | 1.23 (0.99–1.57) | − 5.108 | 0.001** |
Range | 0.45–5.72 | 0.53–3.97 | ||